| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 1.23e-10 | 5 | 46 | 4 | GO:0005471 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 8.04e-09 | 11 | 46 | 4 | GO:0015217 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 2.43e-08 | 14 | 46 | 4 | GO:0005347 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 2.11e-07 | 23 | 46 | 4 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 3.55e-07 | 26 | 46 | 4 | GO:0000295 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 5.61e-07 | 29 | 46 | 4 | GO:0015216 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 9.60e-07 | 33 | 46 | 4 | GO:0015215 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.91e-06 | 39 | 46 | 4 | GO:0015605 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.02e-05 | 59 | 46 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.02e-05 | 59 | 46 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 5.17e-05 | 5 | 46 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 5.17e-05 | 5 | 46 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 2.31e-04 | 10 | 46 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 2.82e-04 | 11 | 46 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.85e-04 | 138 | 46 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase inhibitor activity | 3.38e-04 | 12 | 46 | 2 | GO:0004861 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 4.64e-04 | 14 | 46 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 5.35e-04 | 15 | 46 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | protein antigen binding | 6.10e-04 | 16 | 46 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 6.91e-04 | 17 | 46 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | cAMP binding | 1.51e-03 | 25 | 46 | 2 | GO:0030552 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.77e-03 | 104 | 46 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | transporter activity | KCNK3 GPR89A GPR89B ABCA3 SLC25A4 SLC25A5 SLC25A6 SLC25A31 NPC1L1 | 2.38e-03 | 1289 | 46 | 9 | GO:0005215 |
| GeneOntologyMolecularFunction | NF-kappaB binding | 3.11e-03 | 36 | 46 | 2 | GO:0051059 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 3.64e-03 | 39 | 46 | 2 | GO:0030551 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase inhibitor activity | 4.02e-03 | 41 | 46 | 2 | GO:0030291 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor binding | 4.02e-03 | 41 | 46 | 2 | GO:0005154 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 4.57e-03 | 293 | 46 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 4.66e-03 | 477 | 46 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.73e-03 | 296 | 46 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 5.09e-03 | 1180 | 46 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.16e-03 | 51 | 46 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase regulator activity | 6.16e-03 | 51 | 46 | 2 | GO:0016538 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 7.13e-03 | 55 | 46 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 8.44e-03 | 60 | 46 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 8.48e-03 | 182 | 46 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 8.74e-03 | 184 | 46 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 9.56e-03 | 64 | 46 | 2 | GO:0036002 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 1.08e-10 | 5 | 46 | 4 | GO:0140021 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 1.51e-09 | 8 | 46 | 4 | GO:1990544 | |
| GeneOntologyBiologicalProcess | ADP transport | 1.06e-08 | 12 | 46 | 4 | GO:0015866 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.90e-08 | 15 | 46 | 4 | GO:1901029 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 1.86e-07 | 23 | 46 | 4 | GO:0035795 | |
| GeneOntologyBiologicalProcess | ATP transport | 1.86e-07 | 23 | 46 | 4 | GO:0015867 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.23e-07 | 24 | 46 | 4 | GO:1901028 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 3.12e-07 | 26 | 46 | 4 | GO:1905709 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 6.52e-07 | 31 | 46 | 4 | GO:1901679 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization | 8.45e-07 | 33 | 46 | 4 | GO:0097345 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 1.87e-06 | 40 | 46 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 1.87e-06 | 40 | 46 | 4 | GO:1902110 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 1.87e-06 | 40 | 46 | 4 | GO:0015868 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization involved in programmed cell death | 2.28e-06 | 42 | 46 | 4 | GO:1902686 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 2.28e-06 | 42 | 46 | 4 | GO:0051503 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 2.75e-06 | 44 | 46 | 4 | GO:0015865 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability | 3.02e-06 | 45 | 46 | 4 | GO:0035794 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability involved in apoptotic process | 4.26e-06 | 49 | 46 | 4 | GO:1902108 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 4.62e-06 | 50 | 46 | 4 | GO:0006862 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane permeability | 4.62e-06 | 50 | 46 | 4 | GO:1905710 | |
| GeneOntologyBiologicalProcess | apoptotic mitochondrial changes | 9.88e-06 | 129 | 46 | 5 | GO:0008637 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability | 1.41e-05 | 66 | 46 | 4 | GO:0046902 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrion organization | 2.97e-05 | 162 | 46 | 5 | GO:0010821 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 2.97e-05 | 162 | 46 | 5 | GO:0015748 | |
| GeneOntologyBiologicalProcess | regulation of membrane permeability | 3.50e-05 | 83 | 46 | 4 | GO:0090559 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 6.19e-05 | 96 | 46 | 4 | GO:1901264 | |
| GeneOntologyBiologicalProcess | adenine transport | 7.26e-05 | 6 | 46 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte apoptotic process | 8.29e-05 | 38 | 46 | 3 | GO:2000108 | |
| GeneOntologyBiologicalProcess | mitochondrial transmembrane transport | 9.11e-05 | 106 | 46 | 4 | GO:1990542 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 1.51e-04 | 525 | 46 | 7 | GO:0009410 | |
| GeneOntologyBiologicalProcess | mitochondrial membrane organization | 2.06e-04 | 131 | 46 | 4 | GO:0007006 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.25e-04 | 249 | 46 | 5 | GO:0015931 | |
| GeneOntologyBiologicalProcess | negative regulation of striated muscle cell apoptotic process | 2.38e-04 | 54 | 46 | 3 | GO:0010664 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid cell apoptotic process | 2.64e-04 | 11 | 46 | 2 | GO:0033034 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell apoptotic process | 2.73e-04 | 141 | 46 | 4 | GO:0010660 | |
| GeneOntologyBiologicalProcess | intracellular pH reduction | 2.94e-04 | 58 | 46 | 3 | GO:0051452 | |
| GeneOntologyBiologicalProcess | hemopoiesis | CDKN2A GPR89A GPR89B ADGRF4 ATP6AP1 NF1 KAT6B SLC25A5 EP300 IFNA5 | 2.97e-04 | 1223 | 46 | 10 | GO:0030097 |
| GeneOntologyBiologicalProcess | purine nucleobase transport | 3.17e-04 | 12 | 46 | 2 | GO:0006863 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 3.18e-04 | 789 | 46 | 8 | GO:0002521 | |
| GeneOntologyBiologicalProcess | muscle cell apoptotic process | 3.46e-04 | 150 | 46 | 4 | GO:0010657 | |
| GeneOntologyBiologicalProcess | negative regulation of gliogenesis | 3.58e-04 | 62 | 46 | 3 | GO:0014014 | |
| GeneOntologyBiologicalProcess | nucleobase transport | 3.74e-04 | 13 | 46 | 2 | GO:0015851 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic signaling pathway | 4.26e-04 | 286 | 46 | 5 | GO:2001234 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic signaling pathway | 5.67e-04 | 467 | 46 | 6 | GO:2001233 | |
| GeneOntologyBiologicalProcess | positive regulation of mitophagy | 5.72e-04 | 16 | 46 | 2 | GO:1901526 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 5.93e-04 | 173 | 46 | 4 | GO:0050768 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to nucleus | 6.32e-04 | 176 | 46 | 4 | GO:1900180 | |
| GeneOntologyBiologicalProcess | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 6.48e-04 | 17 | 46 | 2 | GO:0061179 | |
| GeneOntologyBiologicalProcess | negative regulation of oligodendrocyte differentiation | 7.28e-04 | 18 | 46 | 2 | GO:0048715 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 7.47e-04 | 184 | 46 | 4 | GO:0051961 | |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | 7.71e-04 | 1133 | 46 | 9 | GO:0001932 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy of mitochondrion | 8.12e-04 | 19 | 46 | 2 | GO:1903599 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell apoptotic process | 8.72e-04 | 84 | 46 | 3 | GO:0010665 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth involved in cardiac muscle cell development | 9.01e-04 | 20 | 46 | 2 | GO:0061051 | |
| GeneOntologyBiologicalProcess | ubiquinone metabolic process | 9.01e-04 | 20 | 46 | 2 | GO:0006743 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 9.45e-04 | 515 | 46 | 6 | GO:0050767 | |
| GeneOntologyBiologicalProcess | apoptotic signaling pathway | 9.47e-04 | 713 | 46 | 7 | GO:0097190 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell apoptotic process | 9.65e-04 | 87 | 46 | 3 | GO:0010656 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | 9.67e-04 | 1421 | 46 | 10 | GO:0019220 | |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | 9.77e-04 | 1423 | 46 | 10 | GO:0051174 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle cell apoptotic process | 9.98e-04 | 88 | 46 | 3 | GO:0010662 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell apoptotic process | 1.06e-03 | 90 | 46 | 3 | GO:0010659 | |
| GeneOntologyBiologicalProcess | regulation of modification of postsynaptic structure | 1.09e-03 | 22 | 46 | 2 | GO:0099159 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 1.10e-03 | 353 | 46 | 5 | GO:0010721 | |
| GeneOntologyBiologicalProcess | mitochondrial transport | 1.12e-03 | 205 | 46 | 4 | GO:0006839 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.13e-03 | 92 | 46 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | 1.17e-03 | 358 | 46 | 5 | GO:0071900 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 1.17e-03 | 537 | 46 | 6 | GO:0030098 | |
| GeneOntologyBiologicalProcess | striated muscle cell apoptotic process | 1.21e-03 | 94 | 46 | 3 | GO:0010658 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 1.21e-03 | 94 | 46 | 3 | GO:0051453 | |
| GeneOntologyBiologicalProcess | negative regulation of glial cell proliferation | 1.30e-03 | 24 | 46 | 2 | GO:0060253 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | 1.35e-03 | 1226 | 46 | 9 | GO:0042325 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | IVNS1ABP CDKN2A CDKN2B HMGCR EREG ILK NF1 RAPGEF2 EP300 IFNA5 | 1.37e-03 | 1488 | 46 | 10 | GO:0031399 |
| GeneOntologyBiologicalProcess | skin development | 1.40e-03 | 373 | 46 | 5 | GO:0043588 | |
| GeneOntologyBiologicalProcess | regulation of protein transport | 1.45e-03 | 560 | 46 | 6 | GO:0051223 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 1.48e-03 | 101 | 46 | 3 | GO:0030641 | |
| GeneOntologyBiologicalProcess | quinone metabolic process | 1.53e-03 | 26 | 46 | 2 | GO:1901661 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 1.60e-03 | 226 | 46 | 4 | GO:0050680 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell proliferation | 1.65e-03 | 228 | 46 | 4 | GO:0048660 | |
| GeneOntologyBiologicalProcess | myelin assembly | 1.77e-03 | 28 | 46 | 2 | GO:0032288 | |
| GeneOntologyBiologicalProcess | myeloid cell development | 1.85e-03 | 109 | 46 | 3 | GO:0061515 | |
| GeneOntologyBiologicalProcess | mitochondrion organization | 1.88e-03 | 589 | 46 | 6 | GO:0007005 | |
| GeneOntologyBiologicalProcess | smooth muscle cell proliferation | 1.90e-03 | 237 | 46 | 4 | GO:0048659 | |
| GeneOntologyBiologicalProcess | regulation of modification of synaptic structure | 1.90e-03 | 29 | 46 | 2 | GO:1905244 | |
| GeneOntologyBiologicalProcess | negative regulation of protein serine/threonine kinase activity | 2.00e-03 | 112 | 46 | 3 | GO:0071901 | |
| GeneOntologyBiologicalProcess | autophagy of mitochondrion | 2.10e-03 | 114 | 46 | 3 | GO:0000422 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to nucleus | 2.10e-03 | 114 | 46 | 3 | GO:1900182 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.15e-03 | 115 | 46 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | 2.25e-03 | 611 | 46 | 6 | GO:0045859 | |
| GeneOntologyBiologicalProcess | regulation of pH | 2.43e-03 | 120 | 46 | 3 | GO:0006885 | |
| GeneOntologyBiologicalProcess | peripheral nervous system axon ensheathment | 2.46e-03 | 33 | 46 | 2 | GO:0032292 | |
| GeneOntologyBiologicalProcess | myelination in peripheral nervous system | 2.46e-03 | 33 | 46 | 2 | GO:0022011 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 2.53e-03 | 625 | 46 | 6 | GO:0051960 | |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 3.47e-07 | 7 | 46 | 3 | GO:0005757 | |
| GeneOntologyCellularComponent | pore complex | 2.50e-05 | 26 | 46 | 3 | GO:0046930 | |
| GeneOntologyCellularComponent | mitochondrial protein-containing complex | 2.16e-04 | 250 | 46 | 5 | GO:0098798 | |
| Domain | Aden_trnslctor | 5.77e-07 | 28 | 45 | 4 | IPR002113 | |
| Domain | Mit_carrier | 1.01e-06 | 32 | 45 | 4 | IPR002067 | |
| Domain | Mit_uncoupling | 2.83e-06 | 12 | 45 | 3 | IPR002030 | |
| Domain | SOLCAR | 7.90e-06 | 53 | 45 | 4 | PS50920 | |
| Domain | - | 7.90e-06 | 53 | 45 | 4 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 7.90e-06 | 53 | 45 | 4 | IPR018108 | |
| Domain | Mito_carr | 7.90e-06 | 53 | 45 | 4 | PF00153 | |
| Domain | Mt_carrier_dom | 7.90e-06 | 53 | 45 | 4 | IPR023395 | |
| Domain | Sterol-sensing | 5.65e-05 | 5 | 45 | 2 | PF12349 | |
| Domain | SSD | 4.35e-04 | 13 | 45 | 2 | IPR000731 | |
| Domain | SSD | 4.35e-04 | 13 | 45 | 2 | PS50156 | |
| Domain | PDZ | 4.74e-03 | 141 | 45 | 3 | PF00595 | |
| Domain | PDZ | 5.42e-03 | 148 | 45 | 3 | SM00228 | |
| Domain | - | 5.63e-03 | 150 | 45 | 3 | 2.30.42.10 | |
| Domain | PDZ | 5.73e-03 | 151 | 45 | 3 | PS50106 | |
| Domain | PDZ | 5.84e-03 | 152 | 45 | 3 | IPR001478 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 8.34e-09 | 10 | 37 | 4 | M47694 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.82e-08 | 13 | 37 | 4 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 2.82e-08 | 13 | 37 | 4 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 2.82e-08 | 13 | 37 | 4 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 3.94e-08 | 14 | 37 | 4 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 5.37e-08 | 15 | 37 | 4 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.15e-08 | 16 | 37 | 4 | M47695 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.20e-07 | 18 | 37 | 4 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.20e-07 | 18 | 37 | 4 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 1.51e-07 | 19 | 37 | 4 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.51e-07 | 19 | 37 | 4 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.89e-07 | 20 | 37 | 4 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.33e-07 | 21 | 37 | 4 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.84e-07 | 22 | 37 | 4 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.84e-07 | 22 | 37 | 4 | M47675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.43e-07 | 23 | 37 | 4 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.43e-07 | 23 | 37 | 4 | M47676 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 2.49e-06 | 37 | 37 | 4 | M1029 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 3.60e-06 | 12 | 37 | 3 | M27728 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 6.36e-05 | 83 | 37 | 4 | M39637 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 9.53e-05 | 178 | 37 | 5 | M2890 | |
| Pathway | KEGG_HUNTINGTONS_DISEASE | 1.06e-04 | 182 | 37 | 5 | M13486 | |
| Pathway | PID_FOXM1_PATHWAY | 1.54e-04 | 40 | 37 | 3 | M176 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.91e-04 | 43 | 37 | 3 | M881 | |
| Pathway | BIOCARTA_ETC_PATHWAY | 2.98e-04 | 10 | 37 | 2 | M15371 | |
| Pathway | REACTOME_RUNX3_REGULATES_P14_ARF | 2.98e-04 | 10 | 37 | 2 | M27824 | |
| Pathway | KEGG_PARKINSONS_DISEASE | 3.60e-04 | 130 | 37 | 4 | M7272 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 3.63e-04 | 11 | 37 | 2 | MM15471 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 3.71e-04 | 131 | 37 | 4 | M5283 | |
| Pathway | KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS | 6.89e-04 | 15 | 37 | 2 | M13465 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 9.99e-04 | 18 | 37 | 2 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 9.99e-04 | 18 | 37 | 2 | M840 | |
| Pathway | WP_GPCRS_ORPHAN | 1.11e-03 | 19 | 37 | 2 | MM15991 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.50e-03 | 325 | 37 | 5 | M12868 | |
| Pathway | BIOCARTA_CELLCYCLE_PATHWAY | 1.64e-03 | 23 | 37 | 2 | M17770 | |
| Pathway | BIOCARTA_CELLCYCLE_PATHWAY | 1.78e-03 | 24 | 37 | 2 | MM1376 | |
| Pathway | WP_CANCER_PATHWAYS | 1.89e-03 | 507 | 37 | 6 | M48302 | |
| Pubmed | 2.68e-12 | 4 | 46 | 4 | 33396658 | ||
| Pubmed | 1.87e-10 | 8 | 46 | 4 | 27641616 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 2.17e-09 | 3 | 46 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 2.17e-09 | 3 | 46 | 3 | 2829183 | |
| Pubmed | Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. | 8.65e-09 | 4 | 46 | 3 | 31489369 | |
| Pubmed | 4.32e-08 | 6 | 46 | 3 | 10620603 | ||
| Pubmed | ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy. | 4.32e-08 | 6 | 46 | 3 | 37624892 | |
| Pubmed | 7.55e-08 | 7 | 46 | 3 | 20435627 | ||
| Pubmed | 7.55e-08 | 7 | 46 | 3 | 21370995 | ||
| Pubmed | 7.55e-08 | 7 | 46 | 3 | 19144660 | ||
| Pubmed | 1.21e-07 | 8 | 46 | 3 | 18215124 | ||
| Pubmed | 4.72e-07 | 12 | 46 | 3 | 16120388 | ||
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 7.48e-07 | 53 | 46 | 4 | 23266187 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.31e-06 | 422 | 46 | 7 | 27342126 | |
| Pubmed | Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome. | 1.71e-06 | 2 | 46 | 2 | 11874489 | |
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 1.71e-06 | 2 | 46 | 2 | 10926541 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 10435599 | ||
| Pubmed | Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans. | 1.71e-06 | 2 | 46 | 2 | 29063720 | |
| Pubmed | CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma. | 1.71e-06 | 2 | 46 | 2 | 20118908 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 33167740 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18368387 | ||
| Pubmed | Genetic variants on chromosome 9p21 and ischemic stroke in Chinese. | 1.71e-06 | 2 | 46 | 2 | 19559344 | |
| Pubmed | Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma. | 1.71e-06 | 2 | 46 | 2 | 32067956 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25770315 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 30238987 | ||
| Pubmed | Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. | 1.71e-06 | 2 | 46 | 2 | 7585567 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 8934534 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 9488045 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 32816910 | ||
| Pubmed | The susceptibility CDKN2 locus may have a role on prognosis of melanoma patients. | 1.71e-06 | 2 | 46 | 2 | 20231302 | |
| Pubmed | Nullifying the CDKN2AB locus promotes mutant K-ras lung tumorigenesis. | 1.71e-06 | 2 | 46 | 2 | 24618618 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 10753221 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 12642863 | ||
| Pubmed | A cell cycle regulator potentially involved in genesis of many tumor types. | 1.71e-06 | 2 | 46 | 2 | 8153634 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 9094671 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26577493 | ||
| Pubmed | Genome-wide association study of susceptibility alleles for coronary artery disease. | 1.71e-06 | 2 | 46 | 2 | 18489844 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29348129 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 27507036 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 35067100 | ||
| Pubmed | Genetic alterations of RD(INK4/ARF) enhancer in human cancer cells. | 1.71e-06 | 2 | 46 | 2 | 23065809 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18284544 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15112341 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17646580 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 30774116 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28481918 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29446543 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17459456 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22226369 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 30041662 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15937071 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 21262917 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 38233830 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24093775 | ||
| Pubmed | Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2B. | 1.71e-06 | 2 | 46 | 2 | 25882552 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26842067 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 21638516 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 31189690 | ||
| Pubmed | NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition. | 1.71e-06 | 2 | 46 | 2 | 23858101 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28892048 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22572823 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16271875 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 1.71e-06 | 2 | 46 | 2 | 14749836 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 37355634 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29432124 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22623142 | ||
| Pubmed | Deletion of RDINK4/ARF enhancer: A novel mutation to "inactivate" the INK4-ARF locus. | 1.71e-06 | 2 | 46 | 2 | 28688373 | |
| Pubmed | Evaluation of alterations in the tumor suppressor genes INK4A and INK4B in human bladder tumors. | 1.71e-06 | 2 | 46 | 2 | 11692873 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 27048932 | ||
| Pubmed | Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer. | 1.71e-06 | 2 | 46 | 2 | 37845622 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 14519636 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28646022 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 32879414 | ||
| Pubmed | p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia. | 1.71e-06 | 2 | 46 | 2 | 15370242 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25982567 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 35973817 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16556444 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18071362 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25308604 | ||
| Pubmed | Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation. | 1.71e-06 | 2 | 46 | 2 | 31091306 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11992549 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19298278 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18925945 | ||
| Pubmed | CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization. | 1.71e-06 | 2 | 46 | 2 | 38265748 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 27486979 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25744911 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 2823266 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25550505 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24302590 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11707341 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 21681782 | ||
| Pubmed | Mutational analysis of genes p14ARF, p15INK4b, p16INK4a, and PTEN in human nervous system tumors. | 1.71e-06 | 2 | 46 | 2 | 18551412 | |
| Pubmed | Common genetic variants in the 9p21 region and their associations with multiple tumours. | 1.71e-06 | 2 | 46 | 2 | 23361049 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 7882351 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24908414 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 31721206 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20596618 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 10828598 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19200577 | ||
| Interaction | SLC25A31 interactions | 1.05e-05 | 60 | 46 | 4 | int:SLC25A31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 2.68e-04 | 124 | 46 | 3 | chr9p21 | |
| Cytoband | 9p22 | 2.90e-04 | 25 | 46 | 2 | 9p22 | |
| Cytoband | 9p21 | 4.20e-04 | 30 | 46 | 2 | 9p21 | |
| Cytoband | 1q21.1 | 1.79e-03 | 62 | 46 | 2 | 1q21.1 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.88e-04 | 17 | 27 | 2 | 486 | |
| GeneFamily | PDZ domain containing | 1.47e-03 | 152 | 27 | 3 | 1220 | |
| GeneFamily | Solute carriers | 2.64e-03 | 395 | 27 | 4 | 752 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-07 | 170 | 46 | 5 | 3229f2a02bfa075aa61118552d0407fc018ab3d1 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.37e-06 | 186 | 46 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-06 | 191 | 46 | 5 | 8b34e06c398056e857a10c7653c70c0b1f181692 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.97e-05 | 172 | 46 | 4 | de4961f4037c439d3e0ec706a257b0ec17f4d5be | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 176 | 46 | 4 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.32e-05 | 177 | 46 | 4 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-05 | 183 | 46 | 4 | 07ca2786e62eca9feecf5e54a11864a960f7641a | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.47e-05 | 191 | 46 | 4 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 193 | 46 | 4 | 0be0c4ca363611c04402b13929bb6d3ff68b9ec7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 196 | 46 | 4 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.94e-05 | 196 | 46 | 4 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-05 | 197 | 46 | 4 | ec92d60f802c9d4bdf9877bed5c0a91a5a5ed5d0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-05 | 197 | 46 | 4 | 8c728cd3c0382c4f3e4b78647b6e1447bb40ace1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-05 | 197 | 46 | 4 | 02cc9d39afefa5e5b6f5d93f9adc3a20050b70dd | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.04e-05 | 197 | 46 | 4 | 7bec9c1bc8851064eb229324493b47a31201c83c | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 198 | 46 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.14e-05 | 198 | 46 | 4 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.24e-05 | 199 | 46 | 4 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.24e-05 | 199 | 46 | 4 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.24e-05 | 199 | 46 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Monocytes-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 9.32e-05 | 85 | 46 | 3 | e73603d6f22bb56159aa5d1a2695775f038e61d8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.50e-04 | 145 | 46 | 3 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.59e-04 | 146 | 46 | 3 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.77e-04 | 148 | 46 | 3 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.46e-04 | 155 | 46 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 155 | 46 | 3 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-04 | 159 | 46 | 3 | 50d951cf27a571c0c5002003c16fbc370fa17eb1 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.88e-04 | 159 | 46 | 3 | c40fe552da3abdb1df87e9e1647468dc038bec0a | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 5.88e-04 | 159 | 46 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.21e-04 | 162 | 46 | 3 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 6.43e-04 | 164 | 46 | 3 | 08c725548e751f815b4df778607270498204b353 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.43e-04 | 164 | 46 | 3 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 6.43e-04 | 164 | 46 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.78e-04 | 167 | 46 | 3 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 6.90e-04 | 168 | 46 | 3 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 7.02e-04 | 169 | 46 | 3 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-04 | 169 | 46 | 3 | 42c31fe94e34f54dbbb5d8b33cedb55badd6232c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.02e-04 | 169 | 46 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | TCGA-Cervix|World / Sample_Type by Project: Shred V9 | 7.14e-04 | 170 | 46 | 3 | a6cbe253bc60f5d5cb361c7e85ed9928a3155ec8 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.26e-04 | 171 | 46 | 3 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.26e-04 | 171 | 46 | 3 | eddc5e05003382603ee49f74b9e2242a43021096 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-04 | 172 | 46 | 3 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-04 | 172 | 46 | 3 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-04 | 173 | 46 | 3 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-04 | 173 | 46 | 3 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-04 | 173 | 46 | 3 | f31e738c2b3b319fb40b0b16b2393a51c9a8999c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.64e-04 | 174 | 46 | 3 | d81a5e767e8882ebca4678af881c94c062f8cea5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.64e-04 | 174 | 46 | 3 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.76e-04 | 175 | 46 | 3 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 7.76e-04 | 175 | 46 | 3 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 176 | 46 | 3 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.89e-04 | 176 | 46 | 3 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-04 | 176 | 46 | 3 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.89e-04 | 176 | 46 | 3 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 176 | 46 | 3 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 7.89e-04 | 176 | 46 | 3 | 7a74217b7fa1032b918f00a3972dff5fab74671a | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 177 | 46 | 3 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.02e-04 | 177 | 46 | 3 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 177 | 46 | 3 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.16e-04 | 178 | 46 | 3 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.16e-04 | 178 | 46 | 3 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.16e-04 | 178 | 46 | 3 | f1cfc348d51362eb8c92c625f21f682afc0352b7 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-04 | 179 | 46 | 3 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.29e-04 | 179 | 46 | 3 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-04 | 179 | 46 | 3 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-04 | 179 | 46 | 3 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-04 | 180 | 46 | 3 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | BLOOD--(5)_Plasma| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.42e-04 | 180 | 46 | 3 | 1ac0a0a715f4a36df0762bb0de44802d6ffa284c | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.42e-04 | 180 | 46 | 3 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | BLOOD--(5)_Plasmablasts| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.42e-04 | 180 | 46 | 3 | 4b9be1b19d4ecd0a3b924e4557a1ecfbcff2d705 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.42e-04 | 180 | 46 | 3 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.56e-04 | 181 | 46 | 3 | 71e55acd1d8e4307e56534c74a50e7be4d1dda0d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-04 | 181 | 46 | 3 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-04 | 181 | 46 | 3 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.70e-04 | 182 | 46 | 3 | 7b86703559438e2d5ef3dad963ee0d772513f313 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.70e-04 | 182 | 46 | 3 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-04 | 182 | 46 | 3 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-04 | 182 | 46 | 3 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.84e-04 | 183 | 46 | 3 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-04 | 183 | 46 | 3 | 905e1e9be0f15be184447df04b134a6aa8279074 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-04 | 183 | 46 | 3 | 92eed783347a372b850de3189e72525082390014 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 8.84e-04 | 183 | 46 | 3 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 8.98e-04 | 184 | 46 | 3 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.98e-04 | 184 | 46 | 3 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-04 | 184 | 46 | 3 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.98e-04 | 184 | 46 | 3 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-04 | 184 | 46 | 3 | 282118f8221fa383ffb81dfb5798a0b7f065f911 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.99e-04 | 43 | 46 | 2 | 52772889cdf2e47f703f1d6418da3dc9e5f7d933 | |
| ToppCell | 18-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 9.12e-04 | 185 | 46 | 3 | f8fc7b12b4e18d23d84e95488be93c4352d325f3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-04 | 185 | 46 | 3 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 9.12e-04 | 185 | 46 | 3 | 3b3268e3f99121124e33086cac88479808d31630 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-04 | 185 | 46 | 3 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-04 | 185 | 46 | 3 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.26e-04 | 186 | 46 | 3 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.26e-04 | 186 | 46 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.26e-04 | 186 | 46 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 9.26e-04 | 186 | 46 | 3 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-04 | 187 | 46 | 3 | f491ec986dd44e2dabdf4a75c3101e3b6c921872 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.40e-04 | 187 | 46 | 3 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.40e-04 | 187 | 46 | 3 | 96dc5dc4dbc1b33c2e66666e9027cfbf7972090b | |
| Drug | dehydroabietylamine | 1.46e-11 | 4 | 46 | 4 | ctd:C000600819 | |
| Drug | closantel | 5.08e-10 | 7 | 46 | 4 | ctd:C023342 | |
| Drug | Clodronate | 7.72e-09 | 3 | 46 | 3 | DB00720 | |
| Drug | AC1L4X2K | 9.17e-07 | 10 | 46 | 3 | CID000193824 | |
| Drug | oleoylcarnitine | 4.24e-06 | 16 | 46 | 3 | CID006441392 | |
| Drug | beta-hydroxypalmitoyl-CoA | 5.15e-06 | 17 | 46 | 3 | CID000440600 | |
| Drug | temozolomide | 5.69e-06 | 127 | 46 | 5 | CID000005394 | |
| Drug | agaric acid | 8.59e-06 | 20 | 46 | 3 | CID000012629 | |
| Drug | phenylsuccinate | 1.00e-05 | 21 | 46 | 3 | CID000095459 | |
| Drug | carboxyatractyloside | 1.20e-05 | 3 | 46 | 2 | ctd:C003853 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.55e-05 | 173 | 46 | 5 | 5950_DN | |
| Drug | mersalyl | 2.62e-05 | 85 | 46 | 4 | CID000010294 | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.69e-05 | 175 | 46 | 5 | 1058_DN | |
| Drug | Verdict | 2.72e-05 | 29 | 46 | 3 | CID000050896 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.84e-05 | 177 | 46 | 5 | 7550_DN | |
| Drug | 2,4-dinitrophenol | 3.28e-05 | 90 | 46 | 4 | CID000001493 | |
| Drug | HCOH (hydroxymethylene) | 3.33e-05 | 31 | 46 | 3 | CID006432217 | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.09e-05 | 191 | 46 | 5 | 6644_DN | |
| Drug | phorbol-13-acetate | 4.76e-05 | 326 | 46 | 6 | CID000499953 | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.97e-05 | 199 | 46 | 5 | 6693_DN | |
| Drug | AC1L1DN5 | 5.36e-05 | 102 | 46 | 4 | CID000002423 | |
| Drug | AC1L1D9R | 5.57e-05 | 103 | 46 | 4 | CID000002254 | |
| Drug | Bongkrekic Acid | 5.96e-05 | 6 | 46 | 2 | ctd:D001865 | |
| Drug | thioacridone | 5.96e-05 | 6 | 46 | 2 | CID002818474 | |
| Drug | racephenicol | 7.24e-05 | 40 | 46 | 3 | CID000005433 | |
| Drug | nimesulide | 8.27e-05 | 114 | 46 | 4 | CID000004495 | |
| Drug | trilinolein | 8.33e-05 | 7 | 46 | 2 | ctd:C009564 | |
| Drug | trilinolenin | 8.33e-05 | 7 | 46 | 2 | ctd:C101314 | |
| Drug | AC1L1FWN | 9.26e-05 | 227 | 46 | 5 | CID000003425 | |
| Drug | sanglifehrin A | 9.65e-05 | 44 | 46 | 3 | CID005388925 | |
| Drug | erionite | 1.11e-04 | 8 | 46 | 2 | CID000061565 | |
| Drug | CID5288005 | 1.25e-04 | 48 | 46 | 3 | CID005288004 | |
| Drug | Sterols | 1.42e-04 | 9 | 46 | 2 | ctd:D013261 | |
| Drug | Stigmasterol | 1.78e-04 | 10 | 46 | 2 | ctd:D013265 | |
| Drug | tifomycin | 1.84e-04 | 263 | 46 | 5 | CID000000298 | |
| Drug | 4-(4-(2,4-dioxothiazolidin-5-ylidenemethyl)-2-methoxyphenoxy)-3-trifluoromethylbenzonitrile | 1.88e-04 | 55 | 46 | 3 | ctd:C575631 | |
| Drug | Ptpc | 1.88e-04 | 55 | 46 | 3 | CID003036276 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 5.17e-12 | 4 | 46 | 4 | DOID:0111517 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.19e-07 | 29 | 46 | 4 | DOID:11984 (implicated_via_orthology) | |
| Disease | primary cutaneous T-cell non-Hodgkin lymphoma (is_implicated_in) | 2.38e-06 | 2 | 46 | 2 | DOID:0060061 (is_implicated_in) | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 2.24e-05 | 35 | 46 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | Perineurioma | 2.37e-05 | 5 | 46 | 2 | C0751691 | |
| Disease | Nerve Sheath Tumors | 2.37e-05 | 5 | 46 | 2 | C0206727 | |
| Disease | Peripheral Nerve Sheath Neoplasm | 2.37e-05 | 5 | 46 | 2 | C0751689 | |
| Disease | renal cell carcinoma (implicated_via_orthology) | 3.55e-05 | 6 | 46 | 2 | DOID:4450 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_marker_for) | 6.21e-05 | 49 | 46 | 3 | DOID:9119 (is_marker_for) | |
| Disease | endometrial cancer (implicated_via_orthology) | 6.62e-05 | 8 | 46 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | Glaucoma | 8.50e-05 | 9 | 46 | 2 | C0017601 | |
| Disease | prostate cancer (is_marker_for) | 1.03e-04 | 156 | 46 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Familial Atypical Mole Melanoma Syndrome | 1.30e-04 | 11 | 46 | 2 | C2314896 | |
| Disease | granulosa cell tumor (is_marker_for) | 1.30e-04 | 11 | 46 | 2 | DOID:2999 (is_marker_for) | |
| Disease | Malignant Glioma | 1.80e-04 | 70 | 46 | 3 | C0555198 | |
| Disease | mixed gliomas | 1.80e-04 | 70 | 46 | 3 | C0259783 | |
| Disease | Benign tumor of pancreas | 1.83e-04 | 13 | 46 | 2 | C0347284 | |
| Disease | Malignant neoplasm of breast | 2.29e-04 | 1074 | 46 | 8 | C0006142 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.09e-04 | 84 | 46 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Glioma | 3.43e-04 | 87 | 46 | 3 | C0017638 | |
| Disease | Pancreatic carcinoma | 4.00e-04 | 19 | 46 | 2 | C0235974 | |
| Disease | reasoning | 4.00e-04 | 19 | 46 | 2 | EFO_0004350 | |
| Disease | Pancreatic Neoplasm | 5.16e-04 | 100 | 46 | 3 | C0030297 | |
| Disease | transitional cell carcinoma (is_implicated_in) | 5.38e-04 | 22 | 46 | 2 | DOID:2671 (is_implicated_in) | |
| Disease | Malignant neoplasm of pancreas | 5.46e-04 | 102 | 46 | 3 | C0346647 | |
| Disease | melanoma | 6.02e-04 | 248 | 46 | 4 | C0025202 | |
| Disease | Noonan Syndrome | 6.42e-04 | 24 | 46 | 2 | C0028326 | |
| Disease | AIDS | 7.55e-04 | 26 | 46 | 2 | EFO_0000765 | |
| Disease | Colorectal cancer | 8.14e-04 | 27 | 46 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 8.14e-04 | 27 | 46 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 8.14e-04 | 27 | 46 | 2 | cv:C0009404 | |
| Disease | visceral adipose tissue measurement | 8.91e-04 | 481 | 46 | 5 | EFO_0004765 | |
| Disease | myelodysplastic syndrome (is_implicated_in) | 1.01e-03 | 30 | 46 | 2 | DOID:0050908 (is_implicated_in) | |
| Disease | colorectal carcinoma (is_marker_for) | 1.53e-03 | 37 | 46 | 2 | DOID:0080199 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RFRGMERMHGSQKMS | 591 | Q17RC7 | |
| QMLRRRMASMQRTGV | 1826 | Q09472 | |
| FDTVRRRMMMQSGRK | 231 | P12236 | |
| FRRMMKSRMMVIGFA | 506 | Q8IZF3 | |
| FDTVRRRMMMQSGRK | 231 | P05141 | |
| QVVMQAMGSCRMRGG | 336 | Q2M329 | |
| MTGREMLVMYARLRG | 1471 | Q99758 | |
| EGQQSSMRMCMGSRR | 221 | Q9HBZ2 | |
| VMGMRMNGRCGAILA | 311 | Q9Y620 | |
| QFRMMTGRMRGQAFI | 341 | Q96IZ5 | |
| AMQGPARTLTMQRGM | 1951 | Q8WYB5 | |
| RIRAPIMRMRTGTQM | 1171 | Q8TEM1 | |
| RRSMSMEGNIRGMIQ | 571 | Q8TEW8 | |
| MRTPRARFQMAVLMG | 401 | Q9Y6Y0 | |
| GLGMRRADVSMANMV | 146 | O14649 | |
| RFQSRSGDAMGMNMI | 646 | P04035 | |
| MGLERMGANSLERMG | 566 | P52272 | |
| MGANSLERMGLERMG | 571 | P52272 | |
| ERACRMMNGMKLSGR | 706 | P52272 | |
| LASTFTRQMGMMLRR | 106 | Q14123 | |
| MMVRRMGRVPGIKFS | 161 | Q9H5P4 | |
| RTLMIMAQMGRISPF | 36 | P01569 | |
| MQVSKRMLAGGVRSM | 1 | Q96FE5 | |
| LISRMMGRCMGAAQF | 111 | Q86WI0 | |
| LCMMGFRRRGMLVNH | 731 | Q9NQV6 | |
| RMAGMFQVTFMAERS | 606 | Q9UHC9 | |
| VRRRMMMQSGEAKRQ | 246 | Q9H0C2 | |
| RRPIQVMMMGSARVA | 46 | P42771 | |
| GMDRGLMGMCVNERR | 101 | Q96AY3 | |
| MVGELLRMSGAFFMR | 196 | O15228 | |
| RMAMARRTMFQKGEV | 206 | B7ZAQ6 | |
| RMAMARRTMFQKGEV | 206 | P0CG08 | |
| MNAMIMRRFSLPGDV | 346 | Q5T2R2 | |
| EMLIMRGARINVMNR | 51 | Q13418 | |
| GRFPMMGIGQMLRKR | 661 | P57058 | |
| FGRRAIQVMMMGSAR | 46 | P42772 | |
| MTAGRRMEMLCAGRV | 1 | O14944 | |
| LRIRQTMMRGTGMIG | 196 | Q9UJV8 | |
| MVNGSMFFRLEMRNG | 1091 | Q16363 | |
| FDTVRRRMMMQSGRK | 231 | P12235 | |
| ETNLGMGRMERRTMI | 1181 | Q9Y4G8 | |
| MGAMRDSIHARRTMQ | 771 | Q8WUH2 | |
| FGRIPMRFSVLMQMR | 41 | Q9BRJ7 | |
| NMMSTGRAALQKRVM | 746 | P21359 | |
| MMAAMATARVRMGPR | 1 | Q15904 | |
| SSRDMQMGPGLFLRM | 96 | Q96JL9 | |
| AAAGGRDGRMLVMDM | 631 | Q9H8Y1 | |
| GGLMEEMNAMLARRR | 261 | P50552 | |
| VRESLVRMMPGRMVG | 336 | P23378 | |
| VRMMPGRMVGVTRDA | 341 | P23378 |